Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Cytisine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,705Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Achieve Life Sciences Reports Q2 2024 Results And Corporate Update
    Achieve Life Sciences Reports Q2 2024 Results And Corporate Update

    13 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/13/2929604/0/en/Achieve-Life-Sciences-Reports-Financial-Results-for-Second-Quarter-2024-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Aug 2024
    Share Share
    Achieve Publishes Cytisinicline Vaping Cessation Trial In JAMA
    Achieve Publishes Cytisinicline Vaping Cessation Trial In JAMA

    06 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/06/2875975/0/en/Achieve-Life-Sciences-Announces-Publication-of-Cytisinicline-Vaping-Cessation-Trial-Results-in-JAMA-Internal-Medicine.html

    GLOBENEWSWIRE
    06 May 2024
    Share Share
    Achieve Life Sciences Cytisinicline ORCA Program to be Presented at 2024(SRNT)
    Achieve Life Sciences Cytisinicline ORCA Program to be Presented at 2024(SRNT)

    20 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/20/2849321/0/en/Achieve-Life-Sciences-Announces-Data-from-Cytisinicline-ORCA-Program-to-be-Presented-at-the-2024-Society-for-Research-on-Nicotine-and-Tobacco-SRNT-Annual-Meeting.html

    GLOBENEWSWIRE
    20 Mar 2024
    Share Share
    Achieve Life presents positive data from ph3 ORCA-2 trial of cytisinicline
    Achieve Life presents positive data from ph3 ORCA-2 trial of cytisinicline

    06 Mar 2023

    // PHARMABIZ

    http://pharmabiz.com/NewsDetails.aspx?aid=156731&sid=2

    PHARMABIZ
    06 Mar 2023
    Share Share
    Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline
    Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline

    21 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/21/2577829/0/en/Achieve-Life-Sciences-Announces-Patent-Granted-by-USPTO-for-New-Cytisinicline-Formulation.html

    GLOBENEWSWIRE
    21 Dec 2022
    Share Share
    Achieve Reports Financial Results for 3Qr 2022 and Provides Corporate Update
    Achieve Reports Financial Results for 3Qr 2022 and Provides Corporate Update

    14 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/14/2555473/0/en/Achieve-Reports-Financial-Results-for-Third-Quarter-2022-and-Provides-Corporate-Update.html#:~:text=Total%20net%20loss%20for%20the,shares%20of%20common%20stock%20outstanding.&text=Achieve%20will%20host%20a%20conference,Monday%2C%20November%2014%2C%202022.

    GLOBENEWSWIRE
    14 Nov 2022
    Share Share